Cytokinetics CYTK Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$784.96M-33.2% | -$589.53M-12.0% | -$526.24M-35.3% | -$388.96M-80.6% | ||
| $10.13M+6.2% | $9.53M-19.9% | $11.89M+105% | $5.81M+155% | ||
| $112.29M+14.8% | $97.84M+35.8% | $72.07M+50.6% | $47.85M+78.3% | ||
| -$510.01M-28.8% | -$395.89M+4.5% | -$414.33M-38.3% | -$299.52M-110% | ||
| $24.81M+535% | $3.91M+176% | $1.42M-87.5% | $11.34M-76.8% | ||
| —— | —— | —— | —— | ||
| $729.46M— | $0— | $0-100% | $523.59M— | ||
| $10.81M+24.5% | $8.68M— | $0— | —— | ||
| $524.46M-43.6% | $930.61M+320% | $221.32M-57.1% | $516.17M+61.3% | ||
| —— | —— | —— | —— | ||
| -$534.82M-33.8% | -$399.8M+3.8% | -$415.75M-33.7% | -$310.85M-62.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytokinetics generate?
- Cytokinetics (CYTK) generated -$523.8M in operating cash flow over the trailing twelve months.
- What is Cytokinetics's free cash flow?
- After $25.1M of capital expenditures, Cytokinetics's free cash flow was -$548.9M over the trailing twelve months, down 34.7% year over year.
- Where does Cytokinetics's cash flow data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
